EIGER BIOPHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.8 USD | +16.67% |
|
-29.11% | -58.43% |
| 04-24 | Motion for Asset Sale Approved for Eiger BioPharmaceuticals, Inc. | CI |
| 04-19 | Selection of Successful Bidder Filed by Eiger BioPharmaceuticals, Inc. | CI |
Chart calendar Eiger BioPharmaceuticals, Inc.
bafb.Y9zPyrhZtmWbhzBbel0VEdXLRavB44gyfXgFqob6kow.Loymn95s_hDz6lowETZiXpGPA_itrf9HEhJH_cWK5v8ZsISFjijHM8TTQw~85dc68d57d9b18bd5e2d0cbcad2e58a8
Upcoming events on Eiger BioPharmaceuticals, Inc.
Past events on Eiger BioPharmaceuticals, Inc.
| 28/12/2023 17:00 | Extraordinary Shareholders Meeting |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 29/06/2023 13:30 | Business Update Call |
| 15/06/2023 18:00 | Annual General Meeting |
| 11/05/2023 21:00 | Q1 2023 Earnings Release |
| 16/03/2023 20:28 | Q4 2022 Earnings Release |
| 08/12/2022 13:30 | HDV Phase 3 D-LIVR Study Results Call |
| 16/11/2022 11:30 | Jefferies London Healthcare Conference |
| 15/11/2022 15:55 | Stifel Healthcare Conference |
| 03/11/2022 20:30 | Q3 2022 Earnings Call |
| 03/11/2022 20:01 | Q3 2022 Earnings Release |
| 18/10/2022 20:00 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 29/09/2022 18:00 | Ladenburg Thalmann Healthcare Conference |
| 14/09/2022 20:45 | Baird Global Healthcare Conference |
| 12/09/2022 19:00 | H.C. Wainwright Global Investment Conference |
| 07/09/2022 | Citi BioPharma Conference |
| 04/08/2022 21:30 | Interim 2022 Earnings Call |
| 04/08/2022 21:05 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,50 - | 0,00 19,0 - | 12,1 12,4 -2.34% | 13,5 15,2 -11.26% | 15,8 18,4 -14.5% | 25,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -76,7 -77,6 1.25% | -92,4 -92,2 -0.22% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -68,9 -71,6 3.8% | -62,1 -42,1 -47.67% | -76,9 -77,5 0.71% | -92,7 -92,1 -0.69% | -71,8 -69,9 -2.75% | -21,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -70,3 -73,5 4.36% | -65,1 -34,4 -89% | -33,9 -46,6 27.41% | -96,8 -96,6 -0.13% | -75,0 -72,8 -3.03% | -24,8 |
|
Net income Million USD | Released Forecast Spread | -70,3 -73,5 4.36% | -65,1 -34,4 -89% | -33,9 -46,7 27.33% | -96,8 -96,7 -0.12% | -75,0 -72,8 -3.03% | -24,8 |
|
EPS USD | Released Forecast Spread | -92,4 -93,4 1.04% | -69,3 -36,1 -91.86% | -30,0 -40,7 26.34% | -69,6 -67,3 -3.46% | -50,8 -49,2 -3.21% | -15,6 |
| Announcement Date | 13/03/20 | 09/03/21 | 10/03/22 | 17/03/23 | 08/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,36 3,39 -0.76% | 2,67 4,05 -33.92% | 4,09 5,08 -19.41% | 4,02 4,26 -5.5% | 2,70 4,42 -39.03% | 4,12 3,82 7.74% | 4,64 4,57 1.63% | 3,21 4,91 -34.65% | 3,80 6,48 -41.3% | 5,55 | 6,05 | 6,56 | 7,06 |
|
EBIT Million USD | Released Forecast Spread | -20,9 -21,1 0.96% | -21,8 -21,0 -3.96% | -20,1 -21,0 4.61% | -26,4 -21,8 -20.86% | -24,5 -23,7 -3.12% | -22,3 -20,2 -10.07% | -20,0 -18,1 -10.33% | -16,9 -12,9 -30.77% | -12,6 -10,7 -17.93% | -7,22 | -5,15 | -4,77 | -4,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,8 -22,0 1.3% | -22,6 -22,1 -2.44% | -21,9 -22,1 1.27% | -27,1 -22,8 -18.93% | -25,1 -24,7 -1.77% | -22,8 -21,0 -8.65% | -20,7 -18,6 -11.52% | -18,0 -13,4 -34.41% | -13,5 -11,2 -19.59% | -7,93 | -5,95 | -5,64 | -5,32 |
|
Net income Million USD | Released Forecast Spread | -21,8 -22,0 1.24% | -22,6 -22,1 -2.46% | -21,9 -22,2 1.21% | -27,1 -22,8 -18.9% | -25,1 -24,7 -1.75% | -22,8 -21,0 -8.66% | -20,7 -18,6 -11.53% | -18,0 -13,4 -34.41% | -13,5 -11,2 -19.61% | -7,93 | -5,95 | -5,64 | -5,32 |
|
EPS USD | Released Forecast Spread | -19,2 -19,0 -1.19% | -19,2 -19,1 -0.52% | -15,3 -18,7 18.18% | -18,6 -15,6 -19.23% | -16,8 -16,1 -4.19% | -15,6 -13,4 -16.85% | -14,1 -11,6 -22.08% | -12,3 -9,15 -34.43% | -7,50 | -5,40 | -3,90 | -3,60 | -2,70 |
| Announcement Date | 10/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 17/03/23 | 11/05/23 | 14/08/23 | 09/11/23 | 08/04/24 | - | - | - | - |
More events
Past sector events for Eiger BioPharmaceuticals, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EIGR Stock
- Calendar Eiger BioPharmaceuticals, Inc.
